Productive steps toward an antimicrobial targeting virulence.
about
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapyComparative Sequence, Structure and Redox Analyses of Klebsiella pneumoniae DsbA Show That Anti-Virulence Target DsbA Enzymes Fall into Distinct ClassesApplication of fragment-based screening to the design of inhibitors of Escherichia coli DsbAThe antibiotic potential of prokaryotic IMP dehydrogenase inhibitorsEscherichia coli resistance to nonbiocidal antibiofilm polysaccharides is rare and mediated by multiple mutations leading to surface physicochemical modificationsHigh-throughput screening of the virulence regulator VirF: a novel antibacterial target for shigellosis.Probing bacterial pathogenesis with genetics, genomics, and chemical biology: past, present, and future approaches.Targeting virulence: salmochelin modification tunes the antibacterial activity spectrum of β-lactams for pathogen-selective killing of Escherichia coli.Syntheses and biological evaluation of 2-amino-3-acyl-tetrahydrobenzothiophene derivatives; antibacterial agents with antivirulence activityInhibition of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells by quorum sensing autoinducer-mimics.Staphylococcus aureus and Escherichia coli have disparate dependences on KsgA for growth and ribosome biogenesis.Small-molecule inhibitors of the pseudaminic acid biosynthetic pathway: targeting motility as a key bacterial virulence factorAntagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase.Identification of a collagen type I adhesin of Bacteroides fragilis.Andrographolide inhibits intracellular Chlamydia trachomatis multiplication and reduces secretion of proinflammatory mediators produced by human epithelial cells.Identification of phenolic compounds that suppress the virulence of Xanthomonas oryzae on rice via the type III secretion system.Crataeva nurvala nanoparticles inhibit virulence factors and biofilm formation in clinical isolates of Pseudomonas aeruginosa.Wall teichoic acid function, biosynthesis, and inhibition.Emerging drugs for complicated skin and skin-structure infections.Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection.Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance.The post-antibiotic era: promising developments in the therapy of infectious diseases.Microbial persistence and the road to drug resistance.Emerging drugs on methicillin-resistant Staphylococcus aureus.Current and emerging drugs for acute bacterial skin and skin structure infections: an update.Pseudomonas aeruginosa Lon and ClpXP proteases: roles in linking carbon catabolite repression system with quorum-sensing system.The putative autophagy regulator Atg7 affects the physiology and pathogenic mechanisms of Cryptococcus neoformans.The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention.Discovery of an inhibitor of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells.A multi-centre clinical evaluation of reactive oxygen topical wound gel in 114 wounds.Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance.Targeting Bacillosamine Biosynthesis in Bacterial Pathogens: Development of Inhibitors to a Bacterial Amino-Sugar Acetyltransferase from Campylobacter jejuni.Plasticity of the malleobactin pathway and its impact on siderophore action in human pathogenic bacteria.3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasB.Limiting damage during infection: lessons from infection tolerance for novel therapeutics.Thinking outside the box: new strategies for antichlamydial control.Nanoparticle-based local antimicrobial drug delivery.Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges.Effect of γ-lactones and γ-lactams compounds on Streptococcus mutans biofilms.Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin-Ciprofloxacin Conjugate and Confers Targeted Antibacterial Activity.
P2860
Q26752975-C850FEFE-3F15-4EEC-AB77-7F7AA055E25BQ27680624-F7F9D3FF-84D1-40F7-A3BF-A1CA963C7306Q27697288-C27CA26C-4C43-44FD-8FD8-5E0C25ED168AQ30356398-3B3DAF5F-4AA7-47B4-96C1-C097082F5A2EQ30541729-3F8118E0-1F9B-4ABC-AE82-59DD1F715A9DQ33541815-169C4DA0-0B07-4B84-9F7B-9CB42DF1C7F3Q33798373-462AA8ED-17D3-4716-BFC7-6987B27139BEQ33877981-F5DEACFB-B5FE-4B5D-8991-8C91F520FB64Q34118181-C1E7DEE8-871E-418B-A8CE-6C3CBFB5FCF7Q34422072-0F0255DB-3365-43C8-9828-DDD88B280796Q34456862-60772DCC-AC10-417A-A924-E2A74DC8D5B5Q34597864-F07F3536-54B9-406D-9398-CEABEC326A90Q34617941-72E254AF-04FB-4B11-9481-81DCA6DE696DQ35118021-E2C7F026-6D30-4CCE-AF70-F3955CD63859Q35975515-2988E8C6-FE29-48C2-B95D-DEB417997540Q35991629-5AA3AA8D-8D8D-4FDB-BD06-B9B293254791Q36200910-C25B3AE9-DFFF-422C-B1C1-272F3EA43E4DQ37629742-306DE610-E6F2-4D74-A61B-0CB6CA1B2F2CQ37765900-BDCCC490-51DA-4BA3-8ABF-BB9C59817BEEQ37838785-EFC816CF-EE8A-4F0C-9F2A-F96CD5D89844Q37876027-F2C10AF2-64A4-49E6-ADEE-B9D18947426CQ38106970-6C0CD648-057B-47E4-99A1-D8FF727D9FB7Q38114534-BD0A7396-B6A1-4C57-A804-1266636F9B0FQ38121142-BD24A86F-35B4-4D40-BF27-267F60B59EE8Q38242081-E5EB9CEB-F0E2-4D3A-8F50-666ACD6D0929Q38516685-F134E805-71A6-45F2-9004-CDF9C059DDBDQ38803529-B1F2A086-40DF-4C53-B314-E2E0DAF3C726Q38852902-9A658A6D-B26C-478C-9B1D-C65B7BB295F4Q39455218-E5152529-FB58-4416-AAAA-270A1491208AQ39944516-71B96CF2-851B-4A52-BB16-8D333A9C0C79Q40072401-46F408AA-4678-4B1F-992E-F953F8232227Q40988449-8BF765AA-F78D-44EB-9748-06F89C4A327BQ41334964-F22D0A97-25AE-4409-ABBD-08F46331E178Q41517764-73B0E2F3-4BCA-4FE7-9CFD-38F4EB75ACD6Q41882238-ED008957-F8AE-45FD-8056-07D6FCAFE014Q43411272-8EBE86ED-D196-4A7E-A829-3F0825C8BA1CQ46223691-09FF900E-7A05-4B06-8A3D-741243001C18Q50049653-4BB80980-DBBA-49C8-81B8-2863D9FE0B6BQ52681344-2374B7BB-0B5B-4CE4-9F27-92EAF1955AD7Q53762102-2D3756AB-9062-4196-B626-36E70FB4557B
P2860
Productive steps toward an antimicrobial targeting virulence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Productive steps toward an antimicrobial targeting virulence.
@en
Productive steps toward an antimicrobial targeting virulence.
@nl
type
label
Productive steps toward an antimicrobial targeting virulence.
@en
Productive steps toward an antimicrobial targeting virulence.
@nl
prefLabel
Productive steps toward an antimicrobial targeting virulence.
@en
Productive steps toward an antimicrobial targeting virulence.
@nl
P2860
P1476
Productive steps toward an antimicrobial targeting virulence.
@en
P2093
Amy K Barczak
Deborah T Hung
P2860
P304
P356
10.1016/J.MIB.2009.06.012
P577
2009-07-22T00:00:00Z